# Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers

> **NCT02966574** · NA · UNKNOWN · sponsor: **Brugmann University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Metastatic Breastcancer

## Interventions

- **DEVICE:** whole body MRI

## Key facts

- **NCT ID:** NCT02966574
- **Lead sponsor:** Brugmann University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12-13
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02966574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02966574, "Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02966574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*